Letter of Authorization: Emergency Use Authorization (EUA) of Remdesivir (GS-5734™) | NLM

Disaster Information Management Research Center | NLM

Letter of Authorization: Emergency Use Authorization (EUA) of Remdesivir (GS-5734™)

10/01/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 10/1/2020. The Food and Drug Administration (FDA) updated this Emergency Use Authorization (EUA) on October 1, 2020, to permit the emergency use of the unapproved product remdesivir for treatment of suspected or laboratory confirmed coronavirus disease 2019 (COVID-19) in adults and children hospitalized with severe disease. (PDF)